Redefined Life Group Switzerland

Benign prostatic hyperplasia (BPH) is a common condition in older men, characterized by an enlarged prostate that can cause urinary obstruction. Transrectal ultrasound (TRUS) is an effective tool for assessing prostate volume and structure, providing valuable information for BPH management.

TRUS enables clinicians to measure the size of the prostate accurately and evaluate the degree of urethral compression. This helps determine the severity of urinary obstruction and guides decisions on medical therapy versus surgical intervention.

In addition, TRUS can identify the presence of nodules or cysts that may contribute to symptoms. Understanding the prostate’s internal architecture allows for personalized treatment planning, such as selecting the appropriate minimally invasive procedure or medication.

TRUS is also useful for monitoring response to treatment over time. By repeating the procedure periodically, clinicians can track changes in prostate size and adjust therapy as needed. Its safety, non-invasive nature, and detailed imaging make it an essential…